GSK-3117391

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C22H33N3O4
Molecular Weight	403.5151
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

ONC(=O)CCC1=NC=C(CN[C@@H](C2CCCCC2)C(=O)OC3CCCC3)C=C1

InChI

InChIKey=AFDPFLDWOXXHQM-NRFANRHFSA-N

InChI=1S/C22H33N3O4/c26-20(25-28)13-12-18-11-10-16(14-23-18)15-24-21(17-6-2-1-3-7-17)22(27)29-19-8-4-5-9-19/h10-11,14,17,19,21,24,28H,1-9,12-13,15H2,(H,25,26)/t21-/m0/s1

HIDE SMILES / InChI

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Histone deacetylase 23 Target ID: CHEMBL2093865 Sources: https://adisinsight.springer.com/drugs/800038780 \| https://www.pharmacodia.com/yaodu/html/v1/chemicals/b304d12155fc51aaf1db47b40292ec54.html	Inhibitor 8297

Patents

Name

Type

Language

GSK-3117391

Code

English

CHR-5154

Code

English

CHR5154

Code

English

CHR 5154 [WHO-DD]

Common Name

English

GSK3117391

Code

English

HDAC-IN-3

Common Name

English

CYCLOHEXANEACETIC ACID, .ALPHA.-(((6-(3-(HYDROXYAMINO)-3-OXOPROPYL)-3-PYRIDINYL)METHYL)AMINO)-, CYCLOPENTYL ESTER, (.ALPHA.S)-

Code

English

Code System Code Type Description

FDA UNII

CKA3P0O1VI

Created by admin on Sat Dec 16 14:07:17 GMT 2023 , Edited by admin on Sat Dec 16 14:07:17 GMT 2023

PRIMARY

DRUG BANK

DB15440

Created by admin on Sat Dec 16 14:07:17 GMT 2023 , Edited by admin on Sat Dec 16 14:07:17 GMT 2023

PRIMARY

CAS

1018673-42-1

Created by admin on Sat Dec 16 14:07:17 GMT 2023 , Edited by admin on Sat Dec 16 14:07:17 GMT 2023

PRIMARY

PUBCHEM

53630042

Created by admin on Sat Dec 16 14:07:17 GMT 2023 , Edited by admin on Sat Dec 16 14:07:17 GMT 2023

PRIMARY

ACTIVE MOIETY


					CKA3P0O1VI

GSK-3117391